Deflate Hype About New Auvelity for Depression

December 2022

You’ll hear buzz about new Rx Auvelity for depression...an ER combo of dextromethorphan 45 mg and bupropion 105 mg given bid.

You might expect bupropion to be the primary active ingredient.

But the manufacturer is actually touting dextromethorphan for its antidepressant effects...as an NMDA receptor blocker.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: PA includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote